| Dr Lilia A Evangelista, MD | |
|
26 Hawkins St, Bronx, NY 10464-1415 | |
| (718) 885-1915 | |
| (718) 885-9221 |
| Full Name | Dr Lilia A Evangelista |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 26 Hawkins St, Bronx, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932158862 | NPI | - | NPPES |
| 01009269 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 123772 (New York) | Primary |
| Entity Name | Montefiore Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063525152 PECOS PAC ID: 3779496021 Enrollment ID: O20031113000235 |
News Archive
CureVac, a clinical stage biopharmaceutical company that has pioneered the development of a new class of therapies and vaccines based on messenger RNA (mRNA), today announced that it has entered into a collaboration and licensing agreement with Janssen Pharmaceuticals, Inc. Under the agreement CureVac will collaborate with Crucell Holland B.V. (a member of the Janssen Pharmaceutical Companies) on the development of an influenza vaccine based on CureVac's RNActive® technology.
When in dysfunction, the vascular endothelium - the tissue that lines the blood vessels throughout our body's entire circulatory system - plays a big role in the development of many human diseases, including diabetes, stroke, heart disease, viral infections and cancer.
EpiCept Corporation has announced that the European Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has issued, as expected following the trend vote announced last month, a negative opinion regarding the marketing authorization application (MAA) for Ceplene (histamine dihydrochloride) for the remission maintenance and prevention of relapse of patients with Acute Myeloid Leukemia (AML) in first remission.
As if you did you didn't already know, without a team of scientists telling you, your physical fitness is on the decline once you hit 30, but now, even more depressingly for the grey brigade of fitness fanatics out, a new study shows that the decline gains speed with each decade, regardless of a person's previous exercise habits.
New evidence of a biological link between diet and depression has come from the first study to analyze associations between diet, body mass index, inflammatory markers and mental health in adolescents.
› Verified 2 days ago
| Entity Name | Yeshiva University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962593210 PECOS PAC ID: 8426947797 Enrollment ID: O20040313000688 |
News Archive
CureVac, a clinical stage biopharmaceutical company that has pioneered the development of a new class of therapies and vaccines based on messenger RNA (mRNA), today announced that it has entered into a collaboration and licensing agreement with Janssen Pharmaceuticals, Inc. Under the agreement CureVac will collaborate with Crucell Holland B.V. (a member of the Janssen Pharmaceutical Companies) on the development of an influenza vaccine based on CureVac's RNActive® technology.
When in dysfunction, the vascular endothelium - the tissue that lines the blood vessels throughout our body's entire circulatory system - plays a big role in the development of many human diseases, including diabetes, stroke, heart disease, viral infections and cancer.
EpiCept Corporation has announced that the European Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has issued, as expected following the trend vote announced last month, a negative opinion regarding the marketing authorization application (MAA) for Ceplene (histamine dihydrochloride) for the remission maintenance and prevention of relapse of patients with Acute Myeloid Leukemia (AML) in first remission.
As if you did you didn't already know, without a team of scientists telling you, your physical fitness is on the decline once you hit 30, but now, even more depressingly for the grey brigade of fitness fanatics out, a new study shows that the decline gains speed with each decade, regardless of a person's previous exercise habits.
New evidence of a biological link between diet and depression has come from the first study to analyze associations between diet, body mass index, inflammatory markers and mental health in adolescents.
› Verified 2 days ago
| Entity Name | United Cerebral Palsy Of New York City, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730302019 PECOS PAC ID: 4688748320 Enrollment ID: O20110414000251 |
News Archive
CureVac, a clinical stage biopharmaceutical company that has pioneered the development of a new class of therapies and vaccines based on messenger RNA (mRNA), today announced that it has entered into a collaboration and licensing agreement with Janssen Pharmaceuticals, Inc. Under the agreement CureVac will collaborate with Crucell Holland B.V. (a member of the Janssen Pharmaceutical Companies) on the development of an influenza vaccine based on CureVac's RNActive® technology.
When in dysfunction, the vascular endothelium - the tissue that lines the blood vessels throughout our body's entire circulatory system - plays a big role in the development of many human diseases, including diabetes, stroke, heart disease, viral infections and cancer.
EpiCept Corporation has announced that the European Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has issued, as expected following the trend vote announced last month, a negative opinion regarding the marketing authorization application (MAA) for Ceplene (histamine dihydrochloride) for the remission maintenance and prevention of relapse of patients with Acute Myeloid Leukemia (AML) in first remission.
As if you did you didn't already know, without a team of scientists telling you, your physical fitness is on the decline once you hit 30, but now, even more depressingly for the grey brigade of fitness fanatics out, a new study shows that the decline gains speed with each decade, regardless of a person's previous exercise habits.
New evidence of a biological link between diet and depression has come from the first study to analyze associations between diet, body mass index, inflammatory markers and mental health in adolescents.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lilia A Evangelista, MD 26 Hawkins St, Bronx, NY 10464-1415 Ph: (718) 885-1915 | Dr Lilia A Evangelista, MD 26 Hawkins St, Bronx, NY 10464-1415 Ph: (718) 885-1915 |
News Archive
CureVac, a clinical stage biopharmaceutical company that has pioneered the development of a new class of therapies and vaccines based on messenger RNA (mRNA), today announced that it has entered into a collaboration and licensing agreement with Janssen Pharmaceuticals, Inc. Under the agreement CureVac will collaborate with Crucell Holland B.V. (a member of the Janssen Pharmaceutical Companies) on the development of an influenza vaccine based on CureVac's RNActive® technology.
When in dysfunction, the vascular endothelium - the tissue that lines the blood vessels throughout our body's entire circulatory system - plays a big role in the development of many human diseases, including diabetes, stroke, heart disease, viral infections and cancer.
EpiCept Corporation has announced that the European Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has issued, as expected following the trend vote announced last month, a negative opinion regarding the marketing authorization application (MAA) for Ceplene (histamine dihydrochloride) for the remission maintenance and prevention of relapse of patients with Acute Myeloid Leukemia (AML) in first remission.
As if you did you didn't already know, without a team of scientists telling you, your physical fitness is on the decline once you hit 30, but now, even more depressingly for the grey brigade of fitness fanatics out, a new study shows that the decline gains speed with each decade, regardless of a person's previous exercise habits.
New evidence of a biological link between diet and depression has come from the first study to analyze associations between diet, body mass index, inflammatory markers and mental health in adolescents.
› Verified 2 days ago
Dr. Sudha Lakshmi Akkapeddi, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2016 Bronxdale Ave, Suite 101, Bronx, NY 10462 Phone: 718-918-1102 Fax: 718-918-9756 | |
Pj Javellana Jamandre, PT, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2705 Williamsbridge Rd, Bronx, NY 10469 Phone: 718-231-5600 | |
Dr. Chantal Theresa Hilaire, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1310 Pugsley Ave, Bronx, NY 10462 Phone: 718-684-4334 | |
Sharif Younis, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 625 E Fordham Rd, Bronx, NY 10458 Phone: 718-933-1900 Fax: 718-563-4039 | |
Dr. Olivera D. Pekovic, M.D. Physical Medicine & Rehabilitation Medicare: May Accept Medicare Assignments Practice Location: 600 E 233rd Street, Dept. Of Physical & Rehabilitation Medicine, Bronx, NY 10466 Phone: 718-920-9171 Fax: 718-920-9212 | |
Dr. Peter Kaganowicz, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 130 W Kingsbridge Rd, Spinal Cord Injury Unit, Bronx, NY 10468 Phone: 718-584-9000 Fax: 718-741-4664 | |
Meg Allyn Krilov, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 111 E 210th St, Bronx, NY 10467 Phone: 718-920-2751 Fax: 718-882-7216 |